Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05704829 |
|---|---|
| Brief Title: | NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer (ADAPTHER2-IV) |
| First Submitted : | December 28, 2022 |
| First Submitted that Met QC Criteria : | January 19, 2023 |
| First Posted : | January 30, 2023 |
| Last Update Submitted that Met QC Criteria : | September 20, 2023 |
| Last Update Posted : | September 21, 2023 |